2 results match your criteria: "the Heart Center First Affiliated Hospital of Wenzhou Medical University Wenzhou China.[Affiliation]"
Clinical Characteristics and Outcomes in Patients With Apical and Nonapical Hypertrophic Cardiomyopathy.
J Am Heart Assoc
October 2024
Department of Cardiovascular Medicine, the Heart Center First Affiliated Hospital of Wenzhou Medical University Wenzhou China.
Article Synopsis
- Apical hypertrophic cardiomyopathy (ApHCM) is a specific type of hypertrophic cardiomyopathy that has better clinical outcomes compared to non-ApHCM, including lower rates of major cardiovascular events and end-stage heart failure.
- In a study with over 5,600 patients, those with ApHCM had significantly lower incidences of serious heart-related issues during a median follow-up of 4.6 years, with 20.4% of ApHCM patients experiencing major adverse events compared to 33.3% of non-ApHCM patients.
- The findings suggest that ApHCM is associated with a decreased risk of critical health outcomes, indicating that patients with this condition may have a
Nonalcoholic fatty liver disease contributes to subclinical atherosclerosis: A systematic review and meta-analysis.
Hepatol Commun
April 2018
Department of Hepatology, NAFLD Research Center First Affiliated Hospital of Wenzhou Medical University Wenzhou China.
Nonalcoholic fatty liver disease (NAFLD) is associated with an increased risk of atherosclerotic cardiovascular disease. In our meta-analysis, we aimed to assess the correlation of NAFLD and four surrogate markers of subclinical atherosclerosis. PubMed, Embase, and the Cochrane Library were searched up until April 2017.
View Article and Find Full Text PDF